|
IPW expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.14579999999942E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.436900E-04 |
| Normal-vs-Stage2 |
1.085810E-01 |
| Normal-vs-Stage3 |
3.626600E-04 |
| Normal-vs-Stage4 |
1.274230E-01 |
| Stage1-vs-Stage2 |
7.065200E-01 |
| Stage1-vs-Stage3 |
3.873600E-01 |
| Stage1-vs-Stage4 |
6.527400E-01 |
| Stage2-vs-Stage3 |
3.722200E-01 |
| Stage2-vs-Stage4 |
9.079800E-01 |
| Stage3-vs-Stage4 |
3.374800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.21949999999316E-05 |
| Normal-vs-AfricanAmerican |
3.704400E-03 |
| Normal-vs-Asian |
2.192700E-04 |
| Caucasian-vs-AfricanAmerican |
7.712600E-01 |
| Caucasian-vs-Asian |
1.346000E-01 |
| AfricanAmerican-vs-Asian |
1.144040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.95540000000372E-05 |
| Normal-vs-Female |
1.059710E-03 |
| Male-vs-Female |
8.552800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.464600E-03 |
| Normal-vs-Extreme_Weight |
3.579500E-04 |
| Normal-vs-Obese |
1.564790E-03 |
| Normal-vs-Extreme_Obese |
9.639100E-04 |
| Normal_Weight-vs-Extreme_Weight |
9.930000E-01 |
| Normal_Weight-vs-Obese |
7.311600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.009600E-01 |
| Extreme_Weight-vs-Obese |
6.979600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.639400E-01 |
| Obese-vs-Extreme_Obese |
2.167200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.808000E-02 |
| Normal-vs-Age(41-60Yrs) |
4.319400E-03 |
| Normal-vs-Age(61-80Yrs) |
2.15539999999237E-05 |
| Normal-vs-Age(81-100Yrs) |
3.72730000000043E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.625600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.883800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.775790E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.089900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.284300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.023400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.787600E-04 |
| Normal-VS-Type2 PRCC |
1.5423999999431E-07 |
| Normal-VS-KIRP CIMP |
4.189600E-02 |
| Normal-VS-Unclassified PRCC |
8.321300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.427200E-04 |
| Type1 PRCC-VS-KIRP CIMP |
9.483600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.390400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.667820E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.193900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.639200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.10750000004156E-06 |
| Normal-vs-N1 |
2.497800E-03 |
| Normal-vs-N2 |
1.983370E-03 |
| N0-vs-N1 |
7.080000E-01 |
| N0-vs-N2 |
2.392000E-01 |
| N1-vs-N2 |
3.329400E-01 |
|
|
